---
title: "Fresenius Medical Care slightly beats market estimates in fourth quarter Fresenius Medical Care, the world's largest dialysis specialist, reported fourth quarter results slightly above market expectations on Tuesday, citing positive development both in its care delivery and care enablement segments. The German company said its adjusted operating income grew 31% to 489 million euros ($512.3 million) in the final quarter of 2024, beating analysts' estimate of 481 million euros in a company-provided consensus. ($1 = 0.9546 euros)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229526364.md"
description: "Fresenius Medical Care reported fourth quarter results that slightly exceeded market expectations, with adjusted operating income rising 31% to 489 million euros ($512.3 million), surpassing analysts' estimates of 481 million euros. The positive performance was attributed to developments in both care delivery and care enablement segments."
datetime: "2025-02-25T06:14:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229526364.md)
  - [en](https://longbridge.com/en/news/229526364.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229526364.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/229526364.md) | [繁體中文](https://longbridge.com/zh-HK/news/229526364.md)


# Fresenius Medical Care slightly beats market estimates in fourth quarter Fresenius Medical Care, the world's largest dialysis specialist, reported fourth quarter results slightly above market expectations on Tuesday, citing positive development both in its care delivery and care enablement segments. The German company said its adjusted operating income grew 31% to 489 million euros ($512.3 million) in the final quarter of 2024, beating analysts' estimate of 481 million euros in a company-provided consensus. ($1 = 0.9546 euros)

(Reuters) - Fresenius Medical Care, the world's largest dialysis specialist, reported fourth quarter results slightly above market expectations on Tuesday, citing positive development both in its care delivery and care enablement segments.

The German company said its adjusted operating income grew 31% to 489 million euros ($512.3 million) in the final quarter of 2024, beating analysts' estimate of 481 million euros in a company-provided consensus.

($1 = 0.9546 euros)

(Reporting by Isabel Demetz in Gdansk; Editing by Milla Nissi)

### Related Stocks

- [Fresenius Medical Care AG (FMS.US)](https://longbridge.com/en/quote/FMS.US.md)

## Related News & Research

- [5 Simple ETFs to Buy With $1,000 and Hold for a Lifetime](https://longbridge.com/en/news/281345615.md)
- [BUZZ-Rosenblatt says finding partner for Snap's smart glasses unit tough](https://longbridge.com/en/news/281357569.md)
- [BUZZ-Street View: Nike's turnaround remains work in progress](https://longbridge.com/en/news/281331333.md)
- [GRAPHIC-Apple's 50-year journey from garage to tech titan](https://longbridge.com/en/news/281342951.md)
- [3 Best Tech Stocks Rated 'Strong Buy' for April 2026: 50%+ Upside](https://longbridge.com/en/news/281347354.md)